MARK SHIF: Open Payments
NPI 1770680464 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 6 payments from 4 companies in 2025. Trend: 2023 $487 · 2024 $421 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $425 |
| Alkermes, Inc. | 1 | $126 |
| Kowa Pharmaceuticals America, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $110 |
Products named: REXULTI, LYBALVI, ZORYVE, COBENFY.
Industry payments across NY — which companies pay providers there.
